Sir Christopher Evans is looking to create a new venture that aims to improve on the drug development productivity of …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

